M&A News: Bain Capital Buys 350-Year-Old Japanese Drugs Firm for $3.4 billion
Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes ...
GlobalData on MSN7h
Bain Capital buys Mitsubishi Tanabe Pharma for $3.3bn
Bain Capital said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare ...
Bain Capital buys Japanese pharma for $3.3B
Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...
Mitsubishi Chemical to Sell Drug Unit to Bain in $3.36 Billion Deal
Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical unit Tanabe Mitsubishi Pharma to U.S. private equity firm Bain Capital in a deal worth 510 billion yen ($3.36 billion) as it ...
Charlwin Mao, the Chinese tech founder welcoming ‘TikTok refugees’
Xiaohongshu, a popular social media app in China, was not well known outside the country until ... fluent in Chinese and American business — skills honed during his time at Bain Capital. “There are ...
Bain Capital proposes to take Surgery Partners private
Bain Capital Private Equity has proposed to acquire the remaining shares of surgical facility operator Surgery Partners it ...
Business Wire2d
Bain Capital Announces Majority Investment in Milacron, a Leading Global Provider of Highly Engineered Plastic Processing Solutions
BOSTON & BATESVILLE, Ind.--(BUSINESS WIRE)--Bain Capital, a leading private investment firm, today announced a majority investment in the Milacron Injection Molding and Extrusion business (or the ...